Target LDL Cholesterol Levels for Primary and Secondary Prevention of Cardiovascular Events

Introduction to LDL Cholesterol Targets

• The European Society of Cardiology recommends a target LDL cholesterol of <70 mg/dL (1.8 mmol/L) or a ≥50% reduction from baseline for patients with established cardiovascular disease 1, 2
• The American Heart Association recommends a target LDL cholesterol of <100 mg/dL (2.6 mmol/L) for primary prevention in high-risk patients without established cardiovascular disease 3, 4, 5

Secondary Prevention (Established Cardiovascular Disease)

• Target LDL-C <70 mg/dL (1.8 mmol/L) or a ≥50% reduction from baseline for patients with established cardiovascular disease 1, 2
• Lowering LDL-C to ≤1.8 mmol/L (70 mg/dL) is associated with the lowest risk of recurrent cardiovascular events 1
• Every 1.0 mmol/L reduction in LDL-C is associated with a corresponding 20-25% reduction in cardiovascular mortality and non-fatal myocardial infarction 1

Primary Prevention (No Established Cardiovascular Disease)

• For high-risk individuals without established cardiovascular disease but with risk factors, the target LDL-C is <100 mg/dL (2.6 mmol/L) 3, 4, 5
• For individuals with diabetes mellitus over age 40 with additional risk factors, the primary goal is LDL-C <100 mg/dL 4, 6, 7
• If LDL-lowering drugs are used, a reduction of at least 30-40% in LDL-C levels should be obtained 4, 5

Special Populations and Considerations

Diabetes Mellitus

• For patients with diabetes and established vascular disease (very high risk): Target LDL-C <70 mg/dL 3
• For patients with diabetes without vascular disease: Target LDL-C <100 mg/dL 3, 6
• If baseline LDL-C is already <100 mg/dL, statin therapy should still be initiated based on risk factor assessment and clinical judgment 4, 5

Chronic Kidney Disease

• Chronic kidney disease (stages 2-5, GFR <90 mL/min/1.73 m²) is considered a coronary heart disease risk-equivalent 1
• LDL-C target should be adapted to the degree of renal failure, generally aiming for <100 mg/dL 1

Familial Hypercholesterolemia

• All patients with familial hypercholesterolemia must be recognized as high-risk patients 1
• Aggressive lipid-lowering therapy is recommended regardless of baseline levels 1

Treatment Approaches to Reach Targets

• Statins are the first-line therapy for LDL-C reduction 1, 8

Monitoring and Follow-up

• In adults with established cardiovascular disease, lipid levels should be measured at least annually and more often if needed to achieve goals 4, 5
• In adults under age 40 with low-risk lipid values (LDL-C <100 mg/dL, HDL-C >50 mg/dL, and triglycerides <150 mg/dL), lipid assessments may be repeated every 2 years 4, 5